142 hedge funds and large institutions have $640M invested in Genmab in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

7.37% more ownership

Funds ownership: 36.4%43.77% (+7.4%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

99% less call options, than puts

Call options by funds: $2K | Put options by funds: $256K

Holders
142
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
$256K
Net Calls
Net Calls Change

Top Buyers

1 +$32.6M
2 +$13.9M
3 +$13M
4
BlackRock
BlackRock
New York
+$12.7M
5
Jennison Associates
Jennison Associates
New York
+$12.6M

Top Sellers

1 -$16.7M
2 -$8.86M
3 -$4.09M
4
Artisan Partners
Artisan Partners
Wisconsin
-$3.49M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$1.52M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$296K
77
$294K
78
$294K
79
$284K
80
$280K
81
$272K
82
$265K
83
$262K
84
$261K
85
$254K
86
$246K
87
$237K
88
$229K
89
$207K
90
$202K
91
$202K
92
$183K
93
$143K
94
$121K
95
$88K
96
$87K
97
$85K
98
$67K
99
$65.2K
100
$64K